Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (9): 574-576.
DOI: 10.19803/j.1672-8629.2019.09.13
JI Hongyan1, LIANG Yu1, ZHAO Jun1, ZHANG Chuanzhou1, YANG Xue1, LI Xiangpeng1, XIA Chen2, WANG Guoping1,*
Received:2019-04-18
Revised:2019-10-21
Online:2019-09-20
Published:2019-10-21
CLC Number:
JI Hongyan, LIANG Yu, ZHAO Jun, ZHANG Chuanzhou, YANG Xue, LI Xiangpeng, XIA Chen, WANG Guoping. One Case of Acute Renal Failure Induced by Vancomycin Combined with Piperacillin and Tazobactam[J]. Chinese Journal of Pharmacovigilance, 2019, 16(9): 574-576.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgywjj.com/EN/10.19803/j.1672-8629.2019.09.13
| [1] 葛均波,徐永健.内科学[M]. 8版.北京:人民卫生出版社,2013:494-495. [2] Klassen S,Krepinsky J C,Prebtani A.Pantoprazole-induced acute interstitial nephritis[J]. CMAJ,2013,185(1):56-59 . [3] Nast CC.Medication-Induced Interstitial Nephritis in the 21st Century[J].ACKD,2017,24(2):72-79. [4] Pingili DS,Okon EE.Vancomycin-Induced Leukocytoclastic Vasculitis and Acute Renal Failure Due to Tubulointerstitial Nephritis[J]. Am J Case Rep,2017(18): 1024-1027. [5] Díaz-Mancebo R,Costero-Fernández O,Vega-Cabrera C,et al.Dress syndrome and acute tubulointerstitial nephritis after treatment with vancomycin and beta-lactams. Case report and literature review[J]. Nefrologia,2012,(32):685-687. [6] Liu T J,Lam J P.Piperacillin-tazobactam-induced acute interstitial nephritis with possible meropenem cross-sensitivity in a patient with osteomyelitis[J]. American Journal of Health-System Pharmacy,2012,69(13):1 109. [7] 赵春丽,裴航,赵保红,等. 95例万古霉素不良反应文献分析[J].中国药物警戒,2018,15(6):354-358. [8] 丁小强,傅辰生.药物所致急性间质性肾炎[J].中华肾病杂志,2005,21(3):123-124. [9] Minhas J S,Wickner P G,Long A A,et al.Immune-mediated reactions to vancomycin: a systematic case review and analysis[J]. Ann Allergy Asthma Immunol,2016,116(6):544-553. [10] Luther M K,Timbrook T T,Caffrey A R,et at. Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis[J].Crit Care Med,2018,46(1):12-20. [11] Hammond D A,Smith M N,Li C H,et al.Systematic Review and Metaanalysis of Acute Kidney Injury Associated With Concomitant Vancomycin and Piperacillin/Tazobactam[J].Clinical Infectious Diseases,2017,64(5):666-674. |
| [1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
| [2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
| [3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
| [4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
| [5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
| [6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
| [7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
| [8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
| [9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
| [10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
| [11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
| [12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
| [13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
| [14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
| [15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
